NASDAQ:CDLX
Cardlytics, Inc.
Cardlytics, Inc.'s revenue fell 16.2% in fiscal 2025 to $233.3M while operating margin rose to −43.6%. Free cash flow was $8.8M, 3.8% of revenue, and the diluted share count rose 9.8%.Summary generated from Cardlytics, Inc.'s SEC filings. Latest annual report filed Mar 4, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$233.3M
Revenue growth−16.2%
Revenue, 5-yr CAGR+4.5%
Gross marginn/a
Operating margin−43.6%
Net margin−44.4%
ROIC−37.7%
Return on equity−326.0%
Debt / equityn/a
Free cash flow$8.8M
FCF margin3.8%
Share count change+9.8%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 267 | 299 | 309 | 278 | 233 |
| Operating income | −123 | −458 | −136 | −195 | −102 |
| Net income | −129 | −465 | −135 | −189 | −103 |
| Free cash flow | −42 | −55 | −1 | −10 | 9 |
Recent filings
- 4Insider transaction report
Oct 2, 2026 - 8-KEntry into a material agreement
Sep 11, 2026 - 4Insider transaction report
Aug 18, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 5, 2026 - 8-KResults of operations and financial condition
Aug 5, 2026 - 8-KNotice of delisting or listing-rule failure
Jun 3, 2026 - 8-KResults of a shareholder vote
May 20, 2026 - 8-KDirector or officer change
May 12, 2026